HRCM
PBYI icon

Hood River Capital Management’s Puma Biotechnology PBYI Stock Holding History

Hood River Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-23,012
Closed -$4.36M – 85
2014
Q4 		$4.36M Buy
23,012
+1,862
+9% +$413K 0.55% 75
2014
Q3 		$5.05M Buy
+21,150
New +$4.34M 0.7% 65

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Hood River Capital Management's PBYI Position: Q1 2015 in Review

Hood River Capital Management sold out of Puma Biotechnology (PBYI) in Q1 2015, closing a stake of 23,012 shares — an estimated $4.36M sold.

Hood River Capital Management first reported a position in PBYI in Q3 2014 and held it in 2 quarters. The position peaked at $5.05M in Q3 2014. 199 funds tracked by Wall St. Rank hold PBYI as of Q1 2015.

  • Hood River Capital Management reported no remaining Puma Biotechnology position as of Q1 2015 after selling out during the quarter.
  • Hood River Capital Management sold 23,012 Puma Biotechnology shares in Q1 2015, an estimated $4.36M.
  • Hood River Capital Management first reported a position in Puma Biotechnology in Q3 2014 and held it in 2 quarters.
  • Hood River Capital Management's Puma Biotechnology position peaked at $5.05M in Q3 2014.
  • 199 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2015.

Based on Hood River Capital Management's 13F filing for Q1 2015, filed 30 Apr 2015.